Login

Brian Cox, CEO of SurgePays, Inc., discusses current $SURG developments at the technology and telecommunications company. 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Financial Pulse: August 2024 Market Update with Michael McCarthy | Drew Tignanelli, Chairman, Financial Consulate Inc.
00:10:00
Michelle Xia on Akeso's Rapid Expansion and Groundbreaking Drug Development | Michelle Xia, CEO, Akeso Inc.
00:10:00
We talk a lot about renewable power, but we also need to build and bring to the market the flexibility components which will complement the energy transition.
00:10:00
Kiliaro CEO Elie Komo on Nasdaq First North Listing and the Future of Social Photo Sharing | Elie Komo, CEO, Kiliaro Group AB.
00:10:00
Cerberus Capital Management Honored as Community Champion at VOA-GNY Gala 2023
00:10:00
Early stage fund that helps accelerate growth|Elizabeth Weil,Founder and Managing Director,Scribble Ventures
00:10:00
Coda Minerals: Advancing Towards Tier One Status with Significant Copper and Cobalt Discoveries in Australia
00:10:00
With the US OTCQX launch, Bango PLC hopes to increase liquidity and diversify its investor base | Paul Larbey, CEO, Bango PLCBGO:LSE
00:10:00
Interview with Fund Manager of Oppenheimer Gold and Special Minerals Fund at the One-to-One Mining Conference
00:10:00
Lindy Resources: Unlocking Guinea's Potential with Premier Bauxite Discovery
00:10:00
Evaluating the Competitive Threat of Fintechs to Emerging Market Banks: Insights from T. Rowe Price
00:10:00
Enhancing Portfolio Alignment with Riskalyze | Chris Sumner, Financial Advisor, RS Financial Group, LLC

© 2017 - Neuhu+